A new UCLA study reveals that a widely used federal hospital safety metric is fundamentally flawed when applied to emergency stroke care, potentially creating incentives that may discourage hospitals ...
The National Institutes of Health-funded Captiva study found that the combination of a low dose of Xarelto and aspirin was unlikely to help prevent recurrent strokes compared with standard of care in ...
Safety-net definitional ambiguity undermines targeted funding, limiting the ability to sustain staffing, infrastructure, and quality improvement needed for optimal stroke care across diverse ...
PORTSMOUTH – Two HCA hospitals in New Hampshire were awarded an ‘A’ in the Fall 2021 Leapfrog Hospital Safety Grade, the top score in a national distinction recognizing the hospital system’s ...
Every year, about 795,000 Americans suffer a stroke; 610,000 are first attacks. However, six out of 10 Americans do not know which hospitals offer specialized treatment for stroke—despite the number ...
Stroke can happen to anyone, at any age and at any time. The number of strokes among younger adults under 55 is rising worldwide, and every day in the UK around 240 people experience the traumatic and ...
Hosted on MSN
NIH stops Johnson & Johnson's blood thinner drug arm in stroke trial after safety review (updated)
Editor’s Note: The story has been updated with comments from J&J The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results